Position in MRK
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$41,124,264
-$604,063 QoQ
Shares Held
341,876
-13.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 3%
Shared 0%
None 97%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NewEdge Advisors, LLC holds $721,115,080 across 17 Drug Manufacturers - General names. MRK ranks #5 (5.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
888,033 | $217,070,786 | |
| 2 | LLY |
ELI LILLY & Co
|
184,095 | $169,325,058 | |
| 3 | ABBV |
AbbVie Inc.
|
632,140 | $137,484,128 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
392,435 | $54,693,665 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
341,876 | $41,124,264 | |
| 6 | AMGN |
Amgen Inc
|
95,939 | $33,756,137 | |
| 7 | PFE |
Pfizer Inc
|
712,319 | $20,001,917 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
226,056 | $13,710,296 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $41,124,264 | 341,876 | Shares | Sole | 2026-05-18 | |
| 2025-12-31 | $41,728,327 | 396,431 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $28,633,390 | 341,158 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $29,003,353 | 366,389 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $36,475,412 | 406,366 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $40,858,724 | 410,723 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $44,729,694 | 393,886 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $81,160,061 | 655,574 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $80,487,256 | 609,983 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $64,358,757 | 590,339 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $56,707,330 | 550,824 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $60,916,111 | 527,915 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $56,957,375 | 535,364 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $58,457,446 | 526,881 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $41,436,551 | 481,149 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,014,280 | 197,590 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $13,064,411 | 159,225 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $11,484,427 | 149,849 | Shares | Sole | 2022-02-17 | |
| 2021-09-30 | $5,594,792 | 74,488 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $7,458,143 | 95,900 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $6,930,471 | 89,901 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $10,492,317 | 128,268 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $28,257,760 | 340,660 | Shares | Sole | 2020-11-03 | |
| 2020-06-30 | $24,193,396 | 312,859 | Shares | Sole | 2020-07-29 | |
| 2020-03-31 | $22,954,423 | 298,342 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||